• Cofoe Medical Technology filed a next-day disclosure return showing 408,700 A shares repurchased for cancellation on July 23.
• Buyback ran at RMB 51.63–53.17 per share; total consideration RMB 21.53 million.
• Total repurchased for cancellation but not yet canceled stood at 904,900 shares as of July 23, including 496,200 shares from July 22.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cofoe Medical Technology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260723-12254180), on July 23, 2026, and is solely responsible for the information contained therein.